Press Releases

09/20/2011

Silicon Biosystems Announces Agreement with Fox Chase Cancer Center

Silicon Biosystems, Inc., announced today its entry with Fox Chase Cancer Center in Philadelphia, PA into an agreement for the company's DEPArray™ technology. Dr. Massimo Cristofanilli, Professor and Chairman of the Department of Medical Oncology, and his colleagues at Fox Chase Cancer Center will use DEPArray™ technology to advance understanding of micrometastatic disease and the genetic heterogeneity of cancers.

application pdfSilicon Biosystems Announces Agreement with Fox Chase Cancer Center

Ask Us a QuestionShare your DEPArray™ storySubscribe to newsletter